Nicolas Duployez

Assistant Professor

Université de Lille

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

ORCID Google Scholar Academic Page

About

Nicolas Duployez is an Assistant Professor at the University of Lille, France. His research primarily focuses on hematological malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Recent articles reflect his work on the genomic landscape of AML, the prognostic impact of genetic mutations, and innovative diagnostic criteria for chronic myelomonocytic leukemia. Professor Duployez's contributions aim to enhance therapeutic strategies and optimize patient outcomes in high-risk hematological conditions.

Nicolas Duployez

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia

The genomic landscape of acute myeloid leukemia: Redefining classifications, ontogeny, and therapeutic strategies

Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration

High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine

Monitoring molecular changes in the management of myelodysplastic syndromes

Oligomonocytic chronic myelomonocytic leukemia is eligible to MDS‐score and not Mono‐dysplasia score

Prognostic impact of CEBPA mutational subgroups in adult AML

Three <i>UBA1</i> clones for a unique VEXAS syndrome

A new combination of monocytic scores to support diagnosis of chronic myelomonocytic leukemia according to novel classifications

A new combination of monocytic scores to support diagnosis of chronic myelomonocytic leukemia according to novel classifications

UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia

CURRENT STATUS OF MOLECULAR ANALYSIS OF MRD IN MDS

European standard clinical practice-Key issues for the medical care of individuals with familial leukemia

French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

JAK inhibition for CD3(-) CD4(+) lymphocytic-variant hypereosinophilic syndrome

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study

Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC

PRATICAL USE OF MONOCYTE SUBSET BY FLOW CYTOMETRY AND SEQUENCING IN DIAGNOSIS AND PROGNOSIS OF CLINICAL RELEVANT MONOCYTOSIS

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia

Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia

Collaborators (2)

Robert Hills

Laurent Mauvieux

How do I reach out?

Meet Kite AI